3-bromo-N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]benzamide;4-methyl-N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]-3-pyridinyl]-2,3-dihydro-1,4-benzoxazine-7-carboxamide;N-[5-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyrazin-2-yl]cyclohexanecarboxamide;N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]benzamide;N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]-1-benzothiophene-2-carboxamide;N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]naphthalene-1-carboxamide;N-[5-[5-pyridin-3-yl-3-(trifluoromethyl)pyrazol-1-yl]-2-pyridinyl]pyridine-3-carboxamide

C150H104BrF21N42O8S — CID 159790615

IUPAC3-bromo-N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]benzamide;4-methyl-N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]-3-pyridinyl]-2,3-dihydro-1,4-benzoxazine-7-carboxamide;N-[5-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyrazin-2-yl]cyclohexanecarboxamide;N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]benzamide;N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]-1-benzothiophene-2-carboxamide;N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]naphthalene-1-carboxamide;N-[5-[5-pyridin-3-yl-3-(trifluoromethyl)pyrazol-1-yl]-2-pyridinyl]pyridine-3-carboxamide
SMILESCN1CCOc2cc(C(=O)Nc3ccc(-n4nc(-c5cccnc5)cc4C(F)(F)F)nc3)ccc21.O=C(Nc1ccc(-n2nc(-c3cccnc3)cc2C(F)(F)F)nn1)c1cc2ccccc2s1.O=C(Nc1ccc(-n2nc(-c3cccnc3)cc2C(F)(F)F)nn1)c1cccc(Br)c1.O=C(Nc1ccc(-n2nc(-c3cccnc3)cc2C(F)(F)F)nn1)c1cccc2ccccc12.O=C(Nc1ccc(-n2nc(-c3cccnc3)cc2C(F)(F)F)nn1)c1ccccc1.O=C(Nc1ccc(-n2nc(C(F)(F)F)cc2-c2cccnc2)cn1)c1cccnc1.O=C(Nc1cnc(-n2nc(-c3cccnc3)cc2C(F)(F)F)cn1)C1CCCCC1
InChIInChI=1S/C24H19F3N6O2.C24H15F3N6O.C22H13F3N6OS.C20H12BrF3N6O.2C20H13F3N6O.C20H19F3N6O/c1-32-9-10-35-20-11-15(4-6-19(20)32)23(34)30-17-5-7-22(29-14-17)33-21(24(25,26)27)12-18(31-33)16-3-2-8-28-13-16;25-24(26,27)20-13-19(16-7-4-12-28-14-16)32-33(20)22-11-10-21(30-31-22)29-23(34)18-9-3-6-15-5-1-2-8-17(15)18;23-22(24,25)18-11-15(14-5-3-9-26-12-14)30-31(18)20-8-7-19(28-29-20)27-21(32)17-10-13-4-1-2-6-16(13)33-17;21-14-5-1-3-12(9-14)19(31)26-17-6-7-18(28-27-17)30-16(20(22,23)24)10-15(29-30)13-4-2-8-25-11-13;21-20(22,23)17-9-16(13-3-1-7-24-10-13)29(28-17)15-5-6-18(26-12-15)27-19(30)14-4-2-8-25-11-14;21-20(22,23)16-11-15(14-7-4-10-24-12-14)28-29(16)18-9-8-17(26-27-18)25-19(30)13-5-2-1-3-6-13;21-20(22,23)16-9-15(14-7-4-8-24-10-14)28-29(16)18-12-25-17(11-26-18)27-19(30)13-5-2-1-3-6-13/h2-8,11-14H,9-10H2,1H3,(H,30,34);1-14H,(H,29,30,34);1-12H,(H,27,28,32);1-11H,(H,26,27,31);1-12H,(H,26,27,30);1-12H,(H,25,26,30);4,7-13H,1-3,5-6H2,(H,25,27,30)
InChIKeyNIMVJXRUVLHTAC-UHFFFAOYSA-N
MW3133.70 g/mol
LogP31.80
Rot. Bonds28

About 3-bromo-N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]benzamide;4-methyl-N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]-3-pyridinyl]-2,3-dihydro-1,4-benzoxazine-7-carboxamide;N-[5-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyrazin-2-yl]cyclohexanecarboxamide;N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]benzamide;N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]-1-benzothiophene-2-carboxamide;N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]naphthalene-1-carboxamide;N-[5-[5-pyridin-3-yl-3-(trifluoromethyl)pyrazol-1-yl]-2-pyridinyl]pyridine-3-carboxamide

3-bromo-N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]benzamide;4-methyl-N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]-3-pyridinyl]-2,3-dihydro-1,4-benzoxazine-7-carboxamide;N-[5-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyrazin-2-yl]cyclohexanecarboxamide;N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]benzamide;N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]-1-benzothiophene-2-carboxamide;N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]naphthalene-1-carboxamide;N-[5-[5-pyridin-3-yl-3-(trifluoromethyl)pyrazol-1-yl]-2-pyridinyl]pyridine-3-carboxamide (PubChem CID 159790615) has the molecular formula C150H104BrF21N42O8S and a molecular weight of 3133.70 g/mol. Its IUPAC name is 3-bromo-N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]benzamide;4-methyl-N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]-3-pyridinyl]-2,3-dihydro-1,4-benzoxazine-7-carboxamide;N-[5-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyrazin-2-yl]cyclohexanecarboxamide;N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]benzamide;N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]-1-benzothiophene-2-carboxamide;N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]naphthalene-1-carboxamide;N-[5-[5-pyridin-3-yl-3-(trifluoromethyl)pyrazol-1-yl]-2-pyridinyl]pyridine-3-carboxamide.

Molecular Properties

Compound Name3-bromo-N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]benzamide;4-methyl-N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]-3-pyridinyl]-2,3-dihydro-1,4-benzoxazine-7-carboxamide;N-[5-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyrazin-2-yl]cyclohexanecarboxamide;N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]benzamide;N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]-1-benzothiophene-2-carboxamide;N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]naphthalene-1-carboxamide;N-[5-[5-pyridin-3-yl-3-(trifluoromethyl)pyrazol-1-yl]-2-pyridinyl]pyridine-3-carboxamide
PubChem CID159790615
Molecular FormulaC150H104BrF21N42O8S
Molecular Weight3133.70 g/mol
Exact Mass3130.76
IUPAC Name3-bromo-N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]benzamide;4-methyl-N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]-3-pyridinyl]-2,3-dihydro-1,4-benzoxazine-7-carboxamide;N-[5-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyrazin-2-yl]cyclohexanecarboxamide;N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]benzamide;N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]-1-benzothiophene-2-carboxamide;N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]naphthalene-1-carboxamide;N-[5-[5-pyridin-3-yl-3-(trifluoromethyl)pyrazol-1-yl]-2-pyridinyl]pyridine-3-carboxamide
SMILESCN1CCOc2cc(C(=O)Nc3ccc(-n4nc(-c5cccnc5)cc4C(F)(F)F)nc3)ccc21.O=C(Nc1ccc(-n2nc(-c3cccnc3)cc2C(F)(F)F)nn1)c1cc2ccccc2s1.O=C(Nc1ccc(-n2nc(-c3cccnc3)cc2C(F)(F)F)nn1)c1cccc(Br)c1.O=C(Nc1ccc(-n2nc(-c3cccnc3)cc2C(F)(F)F)nn1)c1cccc2ccccc12.O=C(Nc1ccc(-n2nc(-c3cccnc3)cc2C(F)(F)F)nn1)c1ccccc1.O=C(Nc1ccc(-n2nc(C(F)(F)F)cc2-c2cccnc2)cn1)c1cccnc1.O=C(Nc1cnc(-n2nc(-c3cccnc3)cc2C(F)(F)F)cn1)C1CCCCC1
InChIInChI=1S/C24H19F3N6O2.C24H15F3N6O.C22H13F3N6OS.C20H12BrF3N6O.2C20H13F3N6O.C20H19F3N6O/c1-32-9-10-35-20-11-15(4-6-19(20)32)23(34)30-17-5-7-22(29-14-17)33-21(24(25,26)27)12-18(31-33)16-3-2-8-28-13-16;25-24(26,27)20-13-19(16-7-4-12-28-14-16)32-33(20)22-11-10-21(30-31-22)29-23(34)18-9-3-6-15-5-1-2-8-17(15)18;23-22(24,25)18-11-15(14-5-3-9-26-12-14)30-31(18)20-8-7-19(28-29-20)27-21(32)17-10-13-4-1-2-6-16(13)33-17;21-14-5-1-3-12(9-14)19(31)26-17-6-7-18(28-27-17)30-16(20(22,23)24)10-15(29-30)13-4-2-8-25-11-13;21-20(22,23)17-9-16(13-3-1-7-24-10-13)29(28-17)15-5-6-18(26-12-15)27-19(30)14-4-2-8-25-11-14;21-20(22,23)16-11-15(14-7-4-10-24-12-14)28-29(16)18-9-8-17(26-27-18)25-19(30)13-5-2-1-3-6-13;21-20(22,23)16-9-15(14-7-4-8-24-10-14)28-29(16)18-12-25-17(11-26-18)27-19(30)13-5-2-1-3-6-13/h2-8,11-14H,9-10H2,1H3,(H,30,34);1-14H,(H,29,30,34);1-12H,(H,27,28,32);1-11H,(H,26,27,31);1-12H,(H,26,27,30);1-12H,(H,25,26,30);4,7-13H,1-3,5-6H2,(H,25,27,30)
InChIKeyNIMVJXRUVLHTAC-UHFFFAOYSA-N
XLogP31.80
TPSA598.71 Ų
H-Bond Donors7
H-Bond Acceptors44
Rotatable Bonds28
Heavy Atoms223
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5003133.70
LogP ≤ 531.80
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1044

Analyze 3-bromo-N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]benzamide;4-methyl-N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]-3-pyridinyl]-2,3-dihydro-1,4-benzoxazine-7-carboxamide;N-[5-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyrazin-2-yl]cyclohexanecarboxamide;N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]benzamide;N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]-1-benzothiophene-2-carboxamide;N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]naphthalene-1-carboxamide;N-[5-[5-pyridin-3-yl-3-(trifluoromethyl)pyrazol-1-yl]-2-pyridinyl]pyridine-3-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

4-bromo-N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]benzamide;3-methoxy-N-[5-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyrazin-2-yl]benzamide;4-methoxy-N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]benzamide;N-[4-(methylamino)-4-oxobutyl]-4-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]benzamide;N-[5-(methylamino)-5-oxopentyl]-4-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]benzamide;N-[5-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyrazin-2-yl]naphthalene-1-carboxamide;N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]oxane-4-carboxamide
CID 159304904

Frequently Asked Questions

What is the IUPAC name of 3-bromo-N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]benzamide;4-methyl-N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]-3-pyridinyl]-2,3-dihydro-1,4-benzoxazine-7-carboxamide;N-[5-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyrazin-2-yl]cyclohexanecarboxamide;N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]benzamide;N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]-1-benzothiophene-2-carboxamide;N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]naphthalene-1-carboxamide;N-[5-[5-pyridin-3-yl-3-(trifluoromethyl)pyrazol-1-yl]-2-pyridinyl]pyridine-3-carboxamide?
The IUPAC name of 3-bromo-N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]benzamide;4-methyl-N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]-3-pyridinyl]-2,3-dihydro-1,4-benzoxazine-7-carboxamide;N-[5-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyrazin-2-yl]cyclohexanecarboxamide;N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]benzamide;N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]-1-benzothiophene-2-carboxamide;N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]naphthalene-1-carboxamide;N-[5-[5-pyridin-3-yl-3-(trifluoromethyl)pyrazol-1-yl]-2-pyridinyl]pyridine-3-carboxamide (CID 159790615) is 3-bromo-N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]benzamide;4-methyl-N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]-3-pyridinyl]-2,3-dihydro-1,4-benzoxazine-7-carboxamide;N-[5-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyrazin-2-yl]cyclohexanecarboxamide;N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]benzamide;N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]-1-benzothiophene-2-carboxamide;N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]naphthalene-1-carboxamide;N-[5-[5-pyridin-3-yl-3-(trifluoromethyl)pyrazol-1-yl]-2-pyridinyl]pyridine-3-carboxamide.
What is the SMILES notation for 3-bromo-N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]benzamide;4-methyl-N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]-3-pyridinyl]-2,3-dihydro-1,4-benzoxazine-7-carboxamide;N-[5-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyrazin-2-yl]cyclohexanecarboxamide;N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]benzamide;N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]-1-benzothiophene-2-carboxamide;N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]naphthalene-1-carboxamide;N-[5-[5-pyridin-3-yl-3-(trifluoromethyl)pyrazol-1-yl]-2-pyridinyl]pyridine-3-carboxamide?
The canonical SMILES for 3-bromo-N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]benzamide;4-methyl-N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]-3-pyridinyl]-2,3-dihydro-1,4-benzoxazine-7-carboxamide;N-[5-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyrazin-2-yl]cyclohexanecarboxamide;N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]benzamide;N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]-1-benzothiophene-2-carboxamide;N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]naphthalene-1-carboxamide;N-[5-[5-pyridin-3-yl-3-(trifluoromethyl)pyrazol-1-yl]-2-pyridinyl]pyridine-3-carboxamide is CN1CCOc2cc(C(=O)Nc3ccc(-n4nc(-c5cccnc5)cc4C(F)(F)F)nc3)ccc21.O=C(Nc1ccc(-n2nc(-c3cccnc3)cc2C(F)(F)F)nn1)c1cc2ccccc2s1.O=C(Nc1ccc(-n2nc(-c3cccnc3)cc2C(F)(F)F)nn1)c1cccc(Br)c1.O=C(Nc1ccc(-n2nc(-c3cccnc3)cc2C(F)(F)F)nn1)c1cccc2ccccc12.O=C(Nc1ccc(-n2nc(-c3cccnc3)cc2C(F)(F)F)nn1)c1ccccc1.O=C(Nc1ccc(-n2nc(C(F)(F)F)cc2-c2cccnc2)cn1)c1cccnc1.O=C(Nc1cnc(-n2nc(-c3cccnc3)cc2C(F)(F)F)cn1)C1CCCCC1.
What is the InChIKey of 3-bromo-N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]benzamide;4-methyl-N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]-3-pyridinyl]-2,3-dihydro-1,4-benzoxazine-7-carboxamide;N-[5-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyrazin-2-yl]cyclohexanecarboxamide;N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]benzamide;N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]-1-benzothiophene-2-carboxamide;N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]naphthalene-1-carboxamide;N-[5-[5-pyridin-3-yl-3-(trifluoromethyl)pyrazol-1-yl]-2-pyridinyl]pyridine-3-carboxamide?
The InChIKey is NIMVJXRUVLHTAC-UHFFFAOYSA-N. The full InChI is InChI=1S/C24H19F3N6O2.C24H15F3N6O.C22H13F3N6OS.C20H12BrF3N6O.2C20H13F3N6O.C20H19F3N6O/c1-32-9-10-35-20-11-15(4-6-19(20)32)23(34)30-17-5-7-22(29-14-17)33-21(24(25,26)27)12-18(31-33)16-3-2-8-28-13-16;25-24(26,27)20-13-19(16-7-4-12-28-14-16)32-33(20)22-11-10-21(30-31-22)29-23(34)18-9-3-6-15-5-1-2-8-17(15)18;23-22(24,25)18-11-15(14-5-3-9-26-12-14)30-31(18)20-8-7-19(28-29-20)27-21(32)17-10-13-4-1-2-6-16(13)33-17;21-14-5-1-3-12(9-14)19(31)26-17-6-7-18(28-27-17)30-16(20(22,23)24)10-15(29-30)13-4-2-8-25-11-13;21-20(22,23)17-9-16(13-3-1-7-24-10-13)29(28-17)15-5-6-18(26-12-15)27-19(30)14-4-2-8-25-11-14;21-20(22,23)16-11-15(14-7-4-10-24-12-14)28-29(16)18-9-8-17(26-27-18)25-19(30)13-5-2-1-3-6-13;21-20(22,23)16-9-15(14-7-4-8-24-10-14)28-29(16)18-12-25-17(11-26-18)27-19(30)13-5-2-1-3-6-13/h2-8,11-14H,9-10H2,1H3,(H,30,34);1-14H,(H,29,30,34);1-12H,(H,27,28,32);1-11H,(H,26,27,31);1-12H,(H,26,27,30);1-12H,(H,25,26,30);4,7-13H,1-3,5-6H2,(H,25,27,30).
What are the key properties of 3-bromo-N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]benzamide;4-methyl-N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]-3-pyridinyl]-2,3-dihydro-1,4-benzoxazine-7-carboxamide;N-[5-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyrazin-2-yl]cyclohexanecarboxamide;N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]benzamide;N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]-1-benzothiophene-2-carboxamide;N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]naphthalene-1-carboxamide;N-[5-[5-pyridin-3-yl-3-(trifluoromethyl)pyrazol-1-yl]-2-pyridinyl]pyridine-3-carboxamide?
3-bromo-N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]benzamide;4-methyl-N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]-3-pyridinyl]-2,3-dihydro-1,4-benzoxazine-7-carboxamide;N-[5-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyrazin-2-yl]cyclohexanecarboxamide;N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]benzamide;N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]-1-benzothiophene-2-carboxamide;N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]naphthalene-1-carboxamide;N-[5-[5-pyridin-3-yl-3-(trifluoromethyl)pyrazol-1-yl]-2-pyridinyl]pyridine-3-carboxamide has a molecular weight of 3133.70 g/mol, XLogP of 31.80, 28 rotatable bonds, 7 hydrogen bond donors, and 44 hydrogen bond acceptors.
Where does this data come from?
All data for 3-bromo-N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]benzamide;4-methyl-N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]-3-pyridinyl]-2,3-dihydro-1,4-benzoxazine-7-carboxamide;N-[5-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyrazin-2-yl]cyclohexanecarboxamide;N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]benzamide;N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]-1-benzothiophene-2-carboxamide;N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]naphthalene-1-carboxamide;N-[5-[5-pyridin-3-yl-3-(trifluoromethyl)pyrazol-1-yl]-2-pyridinyl]pyridine-3-carboxamide is sourced from PubChem (CID 159790615), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).